nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—ABCB1—Mitomycin—urinary bladder cancer	0.0798	0.155	CbGbCtD
Quinine—SLC22A2—Cisplatin—urinary bladder cancer	0.0627	0.122	CbGbCtD
Quinine—SLCO1A2—Methotrexate—urinary bladder cancer	0.0401	0.0781	CbGbCtD
Quinine—CYP3A4—Thiotepa—urinary bladder cancer	0.0362	0.0706	CbGbCtD
Quinine—CYP2E1—Etoposide—urinary bladder cancer	0.0324	0.0631	CbGbCtD
Quinine—CYP2C8—Fluorouracil—urinary bladder cancer	0.029	0.0565	CbGbCtD
Quinine—CYP3A5—Etoposide—urinary bladder cancer	0.0252	0.0491	CbGbCtD
Quinine—CYP2C8—Etoposide—urinary bladder cancer	0.0242	0.0472	CbGbCtD
Quinine—ABCB1—Gemcitabine—urinary bladder cancer	0.023	0.0447	CbGbCtD
Quinine—CYP1A2—Fluorouracil—urinary bladder cancer	0.0225	0.0438	CbGbCtD
Quinine—CYP2C9—Fluorouracil—urinary bladder cancer	0.0202	0.0394	CbGbCtD
Quinine—CYP1A2—Etoposide—urinary bladder cancer	0.0187	0.0365	CbGbCtD
Quinine—CYP2C9—Cisplatin—urinary bladder cancer	0.0172	0.0335	CbGbCtD
Quinine—ABCB1—Cisplatin—urinary bladder cancer	0.0167	0.0325	CbGbCtD
Quinine—ABCB1—Etoposide—urinary bladder cancer	0.0164	0.0319	CbGbCtD
Quinine—ABCB1—Doxorubicin—urinary bladder cancer	0.0112	0.0218	CbGbCtD
Quinine—ABCB1—Methotrexate—urinary bladder cancer	0.0108	0.0211	CbGbCtD
Quinine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0105	0.0205	CbGbCtD
Quinine—CYP3A4—Etoposide—urinary bladder cancer	0.00982	0.0191	CbGbCtD
Quinine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0067	0.013	CbGbCtD
Quinine—CYP2C19—urine—urinary bladder cancer	0.0046	0.048	CbGeAlD
Quinine—KCNN4—prostate gland—urinary bladder cancer	0.00402	0.0419	CbGeAlD
Quinine—CYP1A2—urine—urinary bladder cancer	0.00376	0.0392	CbGeAlD
Quinine—CYP2C9—urine—urinary bladder cancer	0.00357	0.0372	CbGeAlD
Quinine—KCNN4—seminal vesicle—urinary bladder cancer	0.0034	0.0355	CbGeAlD
Quinine—CYP2E1—urine—urinary bladder cancer	0.00338	0.0353	CbGeAlD
Quinine—KCNN4—epithelium—urinary bladder cancer	0.00295	0.0308	CbGeAlD
Quinine—KCNN4—smooth muscle tissue—urinary bladder cancer	0.00285	0.0297	CbGeAlD
Quinine—CYP3A4—urine—urinary bladder cancer	0.00272	0.0284	CbGeAlD
Quinine—KCNN4—urethra—urinary bladder cancer	0.00269	0.0281	CbGeAlD
Quinine—CYP2D6—urine—urinary bladder cancer	0.00268	0.0279	CbGeAlD
Quinine—SLC22A4—prostate gland—urinary bladder cancer	0.00225	0.0235	CbGeAlD
Quinine—KCNN4—female reproductive system—urinary bladder cancer	0.00219	0.0229	CbGeAlD
Quinine—CHRM2—prostate gland—urinary bladder cancer	0.00218	0.0228	CbGeAlD
Quinine—SLC22A2—renal system—urinary bladder cancer	0.00207	0.0216	CbGeAlD
Quinine—KCNN4—vagina—urinary bladder cancer	0.00198	0.0207	CbGeAlD
Quinine—SLC22A4—seminal vesicle—urinary bladder cancer	0.0019	0.0199	CbGeAlD
Quinine—KCNH2—prostate gland—urinary bladder cancer	0.00157	0.0164	CbGeAlD
Quinine—SLC22A4—renal system—urinary bladder cancer	0.00153	0.016	CbGeAlD
Quinine—SLC22A5—prostate gland—urinary bladder cancer	0.00149	0.0155	CbGeAlD
Quinine—SLC22A1—renal system—urinary bladder cancer	0.00146	0.0152	CbGeAlD
Quinine—SLCO1A2—renal system—urinary bladder cancer	0.00141	0.0147	CbGeAlD
Quinine—KCNH2—seminal vesicle—urinary bladder cancer	0.00133	0.0139	CbGeAlD
Quinine—CYP3A5—prostate gland—urinary bladder cancer	0.0013	0.0136	CbGeAlD
Quinine—KCNN4—lymph node—urinary bladder cancer	0.00128	0.0134	CbGeAlD
Quinine—SLC22A5—seminal vesicle—urinary bladder cancer	0.00126	0.0131	CbGeAlD
Quinine—SLC22A4—female reproductive system—urinary bladder cancer	0.00123	0.0128	CbGeAlD
Quinine—CYP2E1—prostate gland—urinary bladder cancer	0.00121	0.0127	CbGeAlD
Quinine—SLC22A4—vagina—urinary bladder cancer	0.00111	0.0116	CbGeAlD
Quinine—KCNH2—renal system—urinary bladder cancer	0.00107	0.0112	CbGeAlD
Quinine—SLC22A1—vagina—urinary bladder cancer	0.00106	0.011	CbGeAlD
Quinine—KCNH2—urethra—urinary bladder cancer	0.00105	0.011	CbGeAlD
Quinine—CYP2E1—seminal vesicle—urinary bladder cancer	0.00103	0.0107	CbGeAlD
Quinine—SLC22A5—renal system—urinary bladder cancer	0.00101	0.0106	CbGeAlD
Quinine—SLC22A5—urethra—urinary bladder cancer	0.000996	0.0104	CbGeAlD
Quinine—CYP2C8—renal system—urinary bladder cancer	0.000982	0.0102	CbGeAlD
Quinine—CYP1A1—epithelium—urinary bladder cancer	0.000977	0.0102	CbGeAlD
Quinine—CYP1A2—renal system—urinary bladder cancer	0.000919	0.00959	CbGeAlD
Quinine—CYP1A1—renal system—urinary bladder cancer	0.000907	0.00946	CbGeAlD
Quinine—CYP1A1—urethra—urinary bladder cancer	0.00089	0.00929	CbGeAlD
Quinine—CYP3A5—renal system—urinary bladder cancer	0.000886	0.00925	CbGeAlD
Quinine—KCNH2—female reproductive system—urinary bladder cancer	0.00086	0.00897	CbGeAlD
Quinine—CYP2E1—renal system—urinary bladder cancer	0.000827	0.00863	CbGeAlD
Quinine—CYP2C19—vagina—urinary bladder cancer	0.000815	0.0085	CbGeAlD
Quinine—SLC22A5—female reproductive system—urinary bladder cancer	0.000812	0.00848	CbGeAlD
Quinine—CYP2E1—urethra—urinary bladder cancer	0.000812	0.00847	CbGeAlD
Quinine—CYP2C8—female reproductive system—urinary bladder cancer	0.000787	0.00821	CbGeAlD
Quinine—KCNH2—vagina—urinary bladder cancer	0.000777	0.00811	CbGeAlD
Quinine—SLC22A5—vagina—urinary bladder cancer	0.000735	0.00767	CbGeAlD
Quinine—CYP1A1—female reproductive system—urinary bladder cancer	0.000726	0.00758	CbGeAlD
Quinine—SLC22A4—lymph node—urinary bladder cancer	0.000718	0.00749	CbGeAlD
Quinine—CYP2C8—vagina—urinary bladder cancer	0.000711	0.00742	CbGeAlD
Quinine—CYP2C9—female reproductive system—urinary bladder cancer	0.000699	0.00729	CbGeAlD
Quinine—ABCB1—prostate gland—urinary bladder cancer	0.000691	0.00721	CbGeAlD
Quinine—CYP3A4—renal system—urinary bladder cancer	0.000665	0.00694	CbGeAlD
Quinine—CYP2E1—female reproductive system—urinary bladder cancer	0.000662	0.00691	CbGeAlD
Quinine—CYP1A1—vagina—urinary bladder cancer	0.000657	0.00685	CbGeAlD
Quinine—CYP2D6—renal system—urinary bladder cancer	0.000655	0.00683	CbGeAlD
Quinine—CYP3A5—vagina—urinary bladder cancer	0.000642	0.0067	CbGeAlD
Quinine—ABCB1—seminal vesicle—urinary bladder cancer	0.000584	0.0061	CbGeAlD
Quinine—CYP3A4—female reproductive system—urinary bladder cancer	0.000533	0.00556	CbGeAlD
Quinine—CYP2D6—female reproductive system—urinary bladder cancer	0.000524	0.00547	CbGeAlD
Quinine—ABCB1—epithelium—urinary bladder cancer	0.000508	0.0053	CbGeAlD
Quinine—KCNH2—lymph node—urinary bladder cancer	0.000503	0.00525	CbGeAlD
Quinine—SLC22A5—lymph node—urinary bladder cancer	0.000475	0.00496	CbGeAlD
Quinine—ABCB1—renal system—urinary bladder cancer	0.000471	0.00491	CbGeAlD
Quinine—ABCB1—urethra—urinary bladder cancer	0.000463	0.00483	CbGeAlD
Quinine—CYP1A1—lymph node—urinary bladder cancer	0.000425	0.00443	CbGeAlD
Quinine—ABCB1—female reproductive system—urinary bladder cancer	0.000377	0.00394	CbGeAlD
Quinine—ABCB1—vagina—urinary bladder cancer	0.000341	0.00356	CbGeAlD
Quinine—Angina pectoris—Epirubicin—urinary bladder cancer	0.000241	0.000948	CcSEcCtD
Quinine—Breast disorder—Doxorubicin—urinary bladder cancer	0.000239	0.000941	CcSEcCtD
Quinine—Anorexia—Etoposide—urinary bladder cancer	0.000239	0.000941	CcSEcCtD
Quinine—Diarrhoea—Thiotepa—urinary bladder cancer	0.000239	0.00094	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Doxorubicin—urinary bladder cancer	0.000238	0.000938	CcSEcCtD
Quinine—Decreased appetite—Cisplatin—urinary bladder cancer	0.000238	0.000936	CcSEcCtD
Quinine—Feeling abnormal—Fluorouracil—urinary bladder cancer	0.000238	0.000936	CcSEcCtD
Quinine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000236	0.00093	CcSEcCtD
Quinine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000235	0.000924	CcSEcCtD
Quinine—Hypotension—Etoposide—urinary bladder cancer	0.000234	0.000922	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Methotrexate—urinary bladder cancer	0.000233	0.000919	CcSEcCtD
Quinine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000233	0.000919	CcSEcCtD
Quinine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000232	0.000914	CcSEcCtD
Quinine—Renal failure—Methotrexate—urinary bladder cancer	0.000231	0.000911	CcSEcCtD
Quinine—Neutropenia—Epirubicin—urinary bladder cancer	0.000231	0.00091	CcSEcCtD
Quinine—Dizziness—Thiotepa—urinary bladder cancer	0.000231	0.000909	CcSEcCtD
Quinine—Urticaria—Fluorouracil—urinary bladder cancer	0.000229	0.000903	CcSEcCtD
Quinine—Asthma—Doxorubicin—urinary bladder cancer	0.000229	0.0009	CcSEcCtD
Quinine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000228	0.000898	CcSEcCtD
Quinine—Sweating—Methotrexate—urinary bladder cancer	0.000226	0.000889	CcSEcCtD
Quinine—Photosensitivity reaction—Epirubicin—urinary bladder cancer	0.000225	0.000888	CcSEcCtD
Quinine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000225	0.000888	CcSEcCtD
Quinine—Dyspnoea—Etoposide—urinary bladder cancer	0.000223	0.00088	CcSEcCtD
Quinine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000223	0.000877	CcSEcCtD
Quinine—Vomiting—Thiotepa—urinary bladder cancer	0.000222	0.000874	CcSEcCtD
Quinine—ABCB1—lymph node—urinary bladder cancer	0.000221	0.0023	CbGeAlD
Quinine—Rash—Thiotepa—urinary bladder cancer	0.00022	0.000866	CcSEcCtD
Quinine—Dermatitis—Thiotepa—urinary bladder cancer	0.00022	0.000865	CcSEcCtD
Quinine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00022	0.000865	CcSEcCtD
Quinine—Headache—Thiotepa—urinary bladder cancer	0.000219	0.000861	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000218	0.00086	CcSEcCtD
Quinine—Decreased appetite—Etoposide—urinary bladder cancer	0.000218	0.000858	CcSEcCtD
Quinine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000217	0.000855	CcSEcCtD
Quinine—Renal failure—Epirubicin—urinary bladder cancer	0.000216	0.000853	CcSEcCtD
Quinine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000216	0.000852	CcSEcCtD
Quinine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000216	0.000852	CcSEcCtD
Quinine—Jaundice—Epirubicin—urinary bladder cancer	0.000215	0.000845	CcSEcCtD
Quinine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000214	0.000842	CcSEcCtD
Quinine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000213	0.000837	CcSEcCtD
Quinine—Haemoglobin—Methotrexate—urinary bladder cancer	0.000212	0.000836	CcSEcCtD
Quinine—Haemorrhage—Methotrexate—urinary bladder cancer	0.000211	0.000832	CcSEcCtD
Quinine—Hepatitis—Methotrexate—urinary bladder cancer	0.000211	0.000832	CcSEcCtD
Quinine—Sweating—Epirubicin—urinary bladder cancer	0.000211	0.000832	CcSEcCtD
Quinine—Asthenia—Gemcitabine—urinary bladder cancer	0.000211	0.000829	CcSEcCtD
Quinine—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.000209	0.000822	CcSEcCtD
Quinine—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000209	0.000822	CcSEcCtD
Quinine—Pruritus—Gemcitabine—urinary bladder cancer	0.000208	0.000818	CcSEcCtD
Quinine—Nausea—Thiotepa—urinary bladder cancer	0.000207	0.000816	CcSEcCtD
Quinine—Urethral disorder—Methotrexate—urinary bladder cancer	0.000207	0.000816	CcSEcCtD
Quinine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000206	0.000813	CcSEcCtD
Quinine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000206	0.000809	CcSEcCtD
Quinine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000205	0.000807	CcSEcCtD
Quinine—Pruritus—Fluorouracil—urinary bladder cancer	0.000204	0.000804	CcSEcCtD
Quinine—Visual impairment—Methotrexate—urinary bladder cancer	0.000204	0.000802	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000202	0.000796	CcSEcCtD
Quinine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000201	0.000794	CcSEcCtD
Quinine—Bradycardia—Epirubicin—urinary bladder cancer	0.000201	0.000793	CcSEcCtD
Quinine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000201	0.000791	CcSEcCtD
Quinine—Renal failure—Doxorubicin—urinary bladder cancer	0.0002	0.000789	CcSEcCtD
Quinine—Erythema multiforme—Methotrexate—urinary bladder cancer	0.0002	0.000787	CcSEcCtD
Quinine—Urticaria—Etoposide—urinary bladder cancer	0.000199	0.000784	CcSEcCtD
Quinine—Haemoglobin—Epirubicin—urinary bladder cancer	0.000199	0.000783	CcSEcCtD
Quinine—Jaundice—Doxorubicin—urinary bladder cancer	0.000199	0.000782	CcSEcCtD
Quinine—Abdominal pain—Etoposide—urinary bladder cancer	0.000198	0.00078	CcSEcCtD
Quinine—Body temperature increased—Etoposide—urinary bladder cancer	0.000198	0.00078	CcSEcCtD
Quinine—Hepatitis—Epirubicin—urinary bladder cancer	0.000198	0.000779	CcSEcCtD
Quinine—Haemorrhage—Epirubicin—urinary bladder cancer	0.000198	0.000779	CcSEcCtD
Quinine—Eye disorder—Methotrexate—urinary bladder cancer	0.000197	0.000778	CcSEcCtD
Quinine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000197	0.000777	CcSEcCtD
Quinine—Tinnitus—Methotrexate—urinary bladder cancer	0.000197	0.000776	CcSEcCtD
Quinine—Asthenia—Cisplatin—urinary bladder cancer	0.000196	0.000773	CcSEcCtD
Quinine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000196	0.000772	CcSEcCtD
Quinine—Sweating—Doxorubicin—urinary bladder cancer	0.000195	0.000769	CcSEcCtD
Quinine—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.000195	0.000769	CcSEcCtD
Quinine—Urethral disorder—Epirubicin—urinary bladder cancer	0.000194	0.000763	CcSEcCtD
Quinine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000191	0.000752	CcSEcCtD
Quinine—Dizziness—Fluorouracil—urinary bladder cancer	0.000191	0.000751	CcSEcCtD
Quinine—Visual impairment—Epirubicin—urinary bladder cancer	0.000191	0.00075	CcSEcCtD
Quinine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00019	0.00075	CcSEcCtD
Quinine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.00019	0.000749	CcSEcCtD
Quinine—Chills—Methotrexate—urinary bladder cancer	0.00019	0.000747	CcSEcCtD
Quinine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000187	0.000737	CcSEcCtD
Quinine—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000187	0.000736	CcSEcCtD
Quinine—Vomiting—Gemcitabine—urinary bladder cancer	0.000187	0.000735	CcSEcCtD
Quinine—Bradycardia—Doxorubicin—urinary bladder cancer	0.000186	0.000733	CcSEcCtD
Quinine—Mental disorder—Methotrexate—urinary bladder cancer	0.000185	0.000729	CcSEcCtD
Quinine—Rash—Gemcitabine—urinary bladder cancer	0.000185	0.000729	CcSEcCtD
Quinine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000185	0.000728	CcSEcCtD
Quinine—Eye disorder—Epirubicin—urinary bladder cancer	0.000185	0.000728	CcSEcCtD
Quinine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000185	0.000727	CcSEcCtD
Quinine—Tinnitus—Epirubicin—urinary bladder cancer	0.000184	0.000726	CcSEcCtD
Quinine—Malnutrition—Methotrexate—urinary bladder cancer	0.000184	0.000724	CcSEcCtD
Quinine—Erythema—Methotrexate—urinary bladder cancer	0.000184	0.000724	CcSEcCtD
Quinine—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000184	0.000724	CcSEcCtD
Quinine—Headache—Gemcitabine—urinary bladder cancer	0.000184	0.000724	CcSEcCtD
Quinine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000183	0.000723	CcSEcCtD
Quinine—Flushing—Epirubicin—urinary bladder cancer	0.000183	0.000723	CcSEcCtD
Quinine—Vomiting—Fluorouracil—urinary bladder cancer	0.000183	0.000722	CcSEcCtD
Quinine—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000183	0.00072	CcSEcCtD
Quinine—Hepatitis—Doxorubicin—urinary bladder cancer	0.000183	0.00072	CcSEcCtD
Quinine—Rash—Fluorouracil—urinary bladder cancer	0.000182	0.000716	CcSEcCtD
Quinine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000182	0.000716	CcSEcCtD
Quinine—Headache—Fluorouracil—urinary bladder cancer	0.000181	0.000712	CcSEcCtD
Quinine—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.000181	0.000712	CcSEcCtD
Quinine—Asthenia—Etoposide—urinary bladder cancer	0.00018	0.000708	CcSEcCtD
Quinine—Urethral disorder—Doxorubicin—urinary bladder cancer	0.000179	0.000706	CcSEcCtD
Quinine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000179	0.000703	CcSEcCtD
Quinine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000178	0.000702	CcSEcCtD
Quinine—Chills—Epirubicin—urinary bladder cancer	0.000177	0.000699	CcSEcCtD
Quinine—Pruritus—Etoposide—urinary bladder cancer	0.000177	0.000698	CcSEcCtD
Quinine—Visual impairment—Doxorubicin—urinary bladder cancer	0.000176	0.000694	CcSEcCtD
Quinine—Nausea—Gemcitabine—urinary bladder cancer	0.000174	0.000686	CcSEcCtD
Quinine—Vomiting—Cisplatin—urinary bladder cancer	0.000174	0.000685	CcSEcCtD
Quinine—Vision blurred—Methotrexate—urinary bladder cancer	0.000173	0.000683	CcSEcCtD
Quinine—Mental disorder—Epirubicin—urinary bladder cancer	0.000173	0.000682	CcSEcCtD
Quinine—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000173	0.000681	CcSEcCtD
Quinine—Rash—Cisplatin—urinary bladder cancer	0.000172	0.000679	CcSEcCtD
Quinine—Dermatitis—Cisplatin—urinary bladder cancer	0.000172	0.000679	CcSEcCtD
Quinine—Malnutrition—Epirubicin—urinary bladder cancer	0.000172	0.000678	CcSEcCtD
Quinine—Erythema—Epirubicin—urinary bladder cancer	0.000172	0.000678	CcSEcCtD
Quinine—Diarrhoea—Etoposide—urinary bladder cancer	0.000171	0.000675	CcSEcCtD
Quinine—Nausea—Fluorouracil—urinary bladder cancer	0.000171	0.000675	CcSEcCtD
Quinine—Eye disorder—Doxorubicin—urinary bladder cancer	0.000171	0.000673	CcSEcCtD
Quinine—Tinnitus—Doxorubicin—urinary bladder cancer	0.000171	0.000672	CcSEcCtD
Quinine—Flushing—Doxorubicin—urinary bladder cancer	0.00017	0.000669	CcSEcCtD
Quinine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00017	0.000669	CcSEcCtD
Quinine—Dizziness—Etoposide—urinary bladder cancer	0.000166	0.000653	CcSEcCtD
Quinine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000651	CcSEcCtD
Quinine—Vertigo—Methotrexate—urinary bladder cancer	0.000165	0.000651	CcSEcCtD
Quinine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000649	CcSEcCtD
Quinine—Leukopenia—Methotrexate—urinary bladder cancer	0.000165	0.000648	CcSEcCtD
Quinine—Chills—Doxorubicin—urinary bladder cancer	0.000164	0.000646	CcSEcCtD
Quinine—Nausea—Cisplatin—urinary bladder cancer	0.000162	0.00064	CcSEcCtD
Quinine—Vision blurred—Epirubicin—urinary bladder cancer	0.000162	0.000639	CcSEcCtD
Quinine—Mental disorder—Doxorubicin—urinary bladder cancer	0.00016	0.000631	CcSEcCtD
Quinine—Convulsion—Methotrexate—urinary bladder cancer	0.000159	0.000628	CcSEcCtD
Quinine—Vomiting—Etoposide—urinary bladder cancer	0.000159	0.000627	CcSEcCtD
Quinine—Erythema—Doxorubicin—urinary bladder cancer	0.000159	0.000627	CcSEcCtD
Quinine—Malnutrition—Doxorubicin—urinary bladder cancer	0.000159	0.000627	CcSEcCtD
Quinine—Agitation—Epirubicin—urinary bladder cancer	0.000158	0.000623	CcSEcCtD
Quinine—Rash—Etoposide—urinary bladder cancer	0.000158	0.000622	CcSEcCtD
Quinine—Dermatitis—Etoposide—urinary bladder cancer	0.000158	0.000622	CcSEcCtD
Quinine—Headache—Etoposide—urinary bladder cancer	0.000157	0.000618	CcSEcCtD
Quinine—Myalgia—Methotrexate—urinary bladder cancer	0.000157	0.000617	CcSEcCtD
Quinine—Chest pain—Methotrexate—urinary bladder cancer	0.000157	0.000617	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000155	0.000612	CcSEcCtD
Quinine—Vertigo—Epirubicin—urinary bladder cancer	0.000155	0.000609	CcSEcCtD
Quinine—Syncope—Epirubicin—urinary bladder cancer	0.000154	0.000608	CcSEcCtD
Quinine—Leukopenia—Epirubicin—urinary bladder cancer	0.000154	0.000607	CcSEcCtD
Quinine—Palpitations—Epirubicin—urinary bladder cancer	0.000152	0.000599	CcSEcCtD
Quinine—Confusional state—Methotrexate—urinary bladder cancer	0.000151	0.000596	CcSEcCtD
Quinine—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000151	0.000596	CcSEcCtD
Quinine—Vision blurred—Doxorubicin—urinary bladder cancer	0.00015	0.000591	CcSEcCtD
Quinine—Convulsion—Epirubicin—urinary bladder cancer	0.000149	0.000587	CcSEcCtD
Quinine—Nausea—Etoposide—urinary bladder cancer	0.000149	0.000586	CcSEcCtD
Quinine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000147	0.00058	CcSEcCtD
Quinine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000147	0.000579	CcSEcCtD
Quinine—Myalgia—Epirubicin—urinary bladder cancer	0.000147	0.000577	CcSEcCtD
Quinine—Chest pain—Epirubicin—urinary bladder cancer	0.000147	0.000577	CcSEcCtD
Quinine—Agitation—Doxorubicin—urinary bladder cancer	0.000146	0.000576	CcSEcCtD
Quinine—Skin disorder—Methotrexate—urinary bladder cancer	0.000146	0.000574	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000146	0.000573	CcSEcCtD
Quinine—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000145	0.000571	CcSEcCtD
Quinine—Vertigo—Doxorubicin—urinary bladder cancer	0.000143	0.000563	CcSEcCtD
Quinine—Anorexia—Methotrexate—urinary bladder cancer	0.000143	0.000563	CcSEcCtD
Quinine—Syncope—Doxorubicin—urinary bladder cancer	0.000143	0.000562	CcSEcCtD
Quinine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000143	0.000561	CcSEcCtD
Quinine—Confusional state—Epirubicin—urinary bladder cancer	0.000142	0.000558	CcSEcCtD
Quinine—Palpitations—Doxorubicin—urinary bladder cancer	0.000141	0.000554	CcSEcCtD
Quinine—Oedema—Epirubicin—urinary bladder cancer	0.00014	0.000553	CcSEcCtD
Quinine—Hypotension—Methotrexate—urinary bladder cancer	0.00014	0.000552	CcSEcCtD
Quinine—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00014	0.000551	CcSEcCtD
Quinine—Shock—Epirubicin—urinary bladder cancer	0.000138	0.000544	CcSEcCtD
Quinine—Convulsion—Doxorubicin—urinary bladder cancer	0.000138	0.000543	CcSEcCtD
Quinine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000138	0.000543	CcSEcCtD
Quinine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000138	0.000542	CcSEcCtD
Quinine—Tachycardia—Epirubicin—urinary bladder cancer	0.000137	0.00054	CcSEcCtD
Quinine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000137	0.000539	CcSEcCtD
Quinine—Skin disorder—Epirubicin—urinary bladder cancer	0.000136	0.000537	CcSEcCtD
Quinine—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000136	0.000535	CcSEcCtD
Quinine—Chest pain—Doxorubicin—urinary bladder cancer	0.000136	0.000534	CcSEcCtD
Quinine—Myalgia—Doxorubicin—urinary bladder cancer	0.000136	0.000534	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000135	0.00053	CcSEcCtD
Quinine—Anorexia—Epirubicin—urinary bladder cancer	0.000134	0.000527	CcSEcCtD
Quinine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000134	0.000527	CcSEcCtD
Quinine—Hypotension—Epirubicin—urinary bladder cancer	0.000131	0.000517	CcSEcCtD
Quinine—Confusional state—Doxorubicin—urinary bladder cancer	0.000131	0.000516	CcSEcCtD
Quinine—Decreased appetite—Methotrexate—urinary bladder cancer	0.00013	0.000514	CcSEcCtD
Quinine—Oedema—Doxorubicin—urinary bladder cancer	0.00013	0.000512	CcSEcCtD
Quinine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00013	0.00051	CcSEcCtD
Quinine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000128	0.000504	CcSEcCtD
Quinine—Shock—Doxorubicin—urinary bladder cancer	0.000128	0.000504	CcSEcCtD
Quinine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000502	CcSEcCtD
Quinine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000127	0.000501	CcSEcCtD
Quinine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000127	0.0005	CcSEcCtD
Quinine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000126	0.000497	CcSEcCtD
Quinine—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000126	0.000495	CcSEcCtD
Quinine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000125	0.000493	CcSEcCtD
Quinine—Anorexia—Doxorubicin—urinary bladder cancer	0.000124	0.000488	CcSEcCtD
Quinine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000124	0.000487	CcSEcCtD
Quinine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000123	0.000483	CcSEcCtD
Quinine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000122	0.000481	CcSEcCtD
Quinine—Hypotension—Doxorubicin—urinary bladder cancer	0.000121	0.000478	CcSEcCtD
Quinine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000121	0.000478	CcSEcCtD
Quinine—Urticaria—Methotrexate—urinary bladder cancer	0.000119	0.00047	CcSEcCtD
Quinine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000119	0.000467	CcSEcCtD
Quinine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000119	0.000467	CcSEcCtD
Quinine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000118	0.000466	CcSEcCtD
Quinine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000116	0.000456	CcSEcCtD
Quinine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000116	0.000456	CcSEcCtD
Quinine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000115	0.000452	CcSEcCtD
Quinine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000113	0.000445	CcSEcCtD
Quinine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000112	0.000442	CcSEcCtD
Quinine—Urticaria—Epirubicin—urinary bladder cancer	0.000112	0.000439	CcSEcCtD
Quinine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000111	0.000437	CcSEcCtD
Quinine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000111	0.000437	CcSEcCtD
Quinine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000111	0.000436	CcSEcCtD
Quinine—Asthenia—Methotrexate—urinary bladder cancer	0.000108	0.000424	CcSEcCtD
Quinine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000107	0.000422	CcSEcCtD
Quinine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000106	0.000419	CcSEcCtD
Quinine—Pruritus—Methotrexate—urinary bladder cancer	0.000106	0.000418	CcSEcCtD
Quinine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000103	0.000408	CcSEcCtD
Quinine—Urticaria—Doxorubicin—urinary bladder cancer	0.000103	0.000407	CcSEcCtD
Quinine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000103	0.000405	CcSEcCtD
Quinine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000103	0.000405	CcSEcCtD
Quinine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000103	0.000404	CcSEcCtD
Quinine—Asthenia—Epirubicin—urinary bladder cancer	0.000101	0.000397	CcSEcCtD
Quinine—Pruritus—Epirubicin—urinary bladder cancer	9.94e-05	0.000391	CcSEcCtD
Quinine—Dizziness—Methotrexate—urinary bladder cancer	9.92e-05	0.000391	CcSEcCtD
Quinine—Diarrhoea—Epirubicin—urinary bladder cancer	9.61e-05	0.000379	CcSEcCtD
Quinine—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.57e-05	0.000377	CcSEcCtD
Quinine—Vomiting—Methotrexate—urinary bladder cancer	9.54e-05	0.000376	CcSEcCtD
Quinine—Rash—Methotrexate—urinary bladder cancer	9.46e-05	0.000373	CcSEcCtD
Quinine—Dermatitis—Methotrexate—urinary bladder cancer	9.45e-05	0.000372	CcSEcCtD
Quinine—Headache—Methotrexate—urinary bladder cancer	9.4e-05	0.00037	CcSEcCtD
Quinine—Asthenia—Doxorubicin—urinary bladder cancer	9.32e-05	0.000367	CcSEcCtD
Quinine—Dizziness—Epirubicin—urinary bladder cancer	9.29e-05	0.000366	CcSEcCtD
Quinine—Pruritus—Doxorubicin—urinary bladder cancer	9.19e-05	0.000362	CcSEcCtD
Quinine—Vomiting—Epirubicin—urinary bladder cancer	8.93e-05	0.000352	CcSEcCtD
Quinine—Nausea—Methotrexate—urinary bladder cancer	8.91e-05	0.000351	CcSEcCtD
Quinine—Diarrhoea—Doxorubicin—urinary bladder cancer	8.89e-05	0.00035	CcSEcCtD
Quinine—Rash—Epirubicin—urinary bladder cancer	8.86e-05	0.000349	CcSEcCtD
Quinine—Dermatitis—Epirubicin—urinary bladder cancer	8.85e-05	0.000348	CcSEcCtD
Quinine—Headache—Epirubicin—urinary bladder cancer	8.8e-05	0.000347	CcSEcCtD
Quinine—Dizziness—Doxorubicin—urinary bladder cancer	8.59e-05	0.000338	CcSEcCtD
Quinine—Nausea—Epirubicin—urinary bladder cancer	8.34e-05	0.000329	CcSEcCtD
Quinine—Vomiting—Doxorubicin—urinary bladder cancer	8.26e-05	0.000325	CcSEcCtD
Quinine—Rash—Doxorubicin—urinary bladder cancer	8.19e-05	0.000323	CcSEcCtD
Quinine—Dermatitis—Doxorubicin—urinary bladder cancer	8.19e-05	0.000322	CcSEcCtD
Quinine—Headache—Doxorubicin—urinary bladder cancer	8.14e-05	0.000321	CcSEcCtD
Quinine—Nausea—Doxorubicin—urinary bladder cancer	7.72e-05	0.000304	CcSEcCtD
Quinine—CYP2C8—Metabolism—GSTT1—urinary bladder cancer	1.81e-05	0.000132	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	1.8e-05	0.000131	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JAG1—urinary bladder cancer	1.8e-05	0.000131	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—RRM2—urinary bladder cancer	1.79e-05	0.000131	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—TYMP—urinary bladder cancer	1.79e-05	0.000131	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.78e-05	0.00013	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	1.77e-05	0.00013	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—GPX1—urinary bladder cancer	1.76e-05	0.000128	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GPX1—urinary bladder cancer	1.76e-05	0.000128	CbGpPWpGaD
Quinine—ABCB1—Metabolism—RRM2—urinary bladder cancer	1.75e-05	0.000128	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—NQO1—urinary bladder cancer	1.74e-05	0.000127	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—NQO1—urinary bladder cancer	1.73e-05	0.000127	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—TYMS—urinary bladder cancer	1.73e-05	0.000126	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	1.73e-05	0.000126	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—ERCC2—urinary bladder cancer	1.73e-05	0.000126	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—ERCC2—urinary bladder cancer	1.73e-05	0.000126	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	1.72e-05	0.000126	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—NCOR1—urinary bladder cancer	1.71e-05	0.000125	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GSTM1—urinary bladder cancer	1.71e-05	0.000125	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PPARG—urinary bladder cancer	1.68e-05	0.000122	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ENO2—urinary bladder cancer	1.66e-05	0.000121	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—HPGDS—urinary bladder cancer	1.66e-05	0.000121	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.65e-05	0.000121	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	1.65e-05	0.000121	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GPX1—urinary bladder cancer	1.64e-05	0.00012	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—NQO1—urinary bladder cancer	1.64e-05	0.00012	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—RRM2—urinary bladder cancer	1.64e-05	0.000119	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—MTHFR—urinary bladder cancer	1.62e-05	0.000119	CbGpPWpGaD
Quinine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	1.62e-05	0.000118	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ENO2—urinary bladder cancer	1.62e-05	0.000118	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—MTHFR—urinary bladder cancer	1.62e-05	0.000118	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NAT2—urinary bladder cancer	1.62e-05	0.000118	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTT1—urinary bladder cancer	1.61e-05	0.000118	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—CREBBP—urinary bladder cancer	1.61e-05	0.000118	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ERCC2—urinary bladder cancer	1.61e-05	0.000117	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.59e-05	0.000116	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.59e-05	0.000116	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	1.57e-05	0.000115	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	1.53e-05	0.000112	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	1.53e-05	0.000112	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—RHOA—urinary bladder cancer	1.52e-05	0.000111	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ENO2—urinary bladder cancer	1.52e-05	0.000111	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—HPGDS—urinary bladder cancer	1.52e-05	0.000111	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—MTHFR—urinary bladder cancer	1.51e-05	0.00011	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.51e-05	0.00011	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—NQO1—urinary bladder cancer	1.5e-05	0.00011	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.48e-05	0.000108	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.47e-05	0.000108	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTT1—urinary bladder cancer	1.47e-05	0.000107	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.46e-05	0.000106	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—S100B—urinary bladder cancer	1.45e-05	0.000106	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.000106	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.45e-05	0.000106	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.000106	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—RRM2—urinary bladder cancer	1.4e-05	0.000102	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.39e-05	0.000101	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.38e-05	0.000101	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RHOA—urinary bladder cancer	1.38e-05	0.000101	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTP1—urinary bladder cancer	1.37e-05	9.97e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—TYMS—urinary bladder cancer	1.35e-05	9.83e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—TYMS—urinary bladder cancer	1.34e-05	9.81e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—NQO1—urinary bladder cancer	1.34e-05	9.78e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—CXCL8—urinary bladder cancer	1.33e-05	9.73e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	9.72e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	9.72e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	9.7e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	9.7e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.32e-05	9.64e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTGS2—urinary bladder cancer	1.32e-05	9.64e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PPARG—urinary bladder cancer	1.32e-05	9.61e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PPARG—urinary bladder cancer	1.31e-05	9.6e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—NCOR1—urinary bladder cancer	1.31e-05	9.55e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.31e-05	9.55e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.3e-05	9.49e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ENO2—urinary bladder cancer	1.3e-05	9.45e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—HPGDS—urinary bladder cancer	1.3e-05	9.45e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	1.29e-05	9.4e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GPX1—urinary bladder cancer	1.27e-05	9.3e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—urinary bladder cancer	1.27e-05	9.3e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GPX1—urinary bladder cancer	1.27e-05	9.29e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.27e-05	9.27e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—TYMS—urinary bladder cancer	1.27e-05	9.27e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CREBBP—urinary bladder cancer	1.27e-05	9.23e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CREBBP—urinary bladder cancer	1.26e-05	9.22e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTT1—urinary bladder cancer	1.26e-05	9.17e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	9.16e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	9.16e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTP1—urinary bladder cancer	1.25e-05	9.14e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	9.14e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.25e-05	9.13e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	9.12e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.24e-05	9.03e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.23e-05	9e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PPARG—urinary bladder cancer	1.23e-05	8.95e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—NQO1—urinary bladder cancer	1.22e-05	8.92e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—CXCL8—urinary bladder cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GPX1—urinary bladder cancer	1.2e-05	8.77e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.19e-05	8.65e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	8.61e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CREBBP—urinary bladder cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—MTHFR—urinary bladder cancer	1.18e-05	8.59e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	8.57e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—TYMS—urinary bladder cancer	1.16e-05	8.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—urinary bladder cancer	1.16e-05	8.45e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TERT—urinary bladder cancer	1.15e-05	8.42e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—urinary bladder cancer	1.15e-05	8.4e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—NCOR1—urinary bladder cancer	1.15e-05	8.4e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTM1—urinary bladder cancer	1.15e-05	8.4e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.13e-05	8.28e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—urinary bladder cancer	1.12e-05	8.16e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	8.1e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GPX1—urinary bladder cancer	1.1e-05	8.04e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—EP300—urinary bladder cancer	1.1e-05	8.01e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.09e-05	7.96e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ERCC2—urinary bladder cancer	1.08e-05	7.9e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.08e-05	7.89e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.08e-05	7.88e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FGFR3—urinary bladder cancer	1.06e-05	7.72e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NQO1—urinary bladder cancer	1.04e-05	7.62e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—TYMS—urinary bladder cancer	1.04e-05	7.58e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTGS2—urinary bladder cancer	1.04e-05	7.56e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTGS2—urinary bladder cancer	1.03e-05	7.55e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.03e-05	7.55e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ESR1—urinary bladder cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTM1—urinary bladder cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—NCOR1—urinary bladder cancer	1.03e-05	7.5e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—urinary bladder cancer	1.02e-05	7.44e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—MTHFR—urinary bladder cancer	1.02e-05	7.42e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.01e-05	7.4e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.01e-05	7.39e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1e-05	7.32e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1e-05	7.32e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1e-05	7.3e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1e-05	7.3e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	9.86e-06	7.2e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GPX1—urinary bladder cancer	9.83e-06	7.18e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	9.7e-06	7.08e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ERCC2—urinary bladder cancer	9.66e-06	7.05e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTGS2—urinary bladder cancer	9.64e-06	7.04e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GPX1—urinary bladder cancer	9.6e-06	7.01e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	9.56e-06	6.98e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PPARG—urinary bladder cancer	9.54e-06	6.96e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PPARG—urinary bladder cancer	9.52e-06	6.95e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—TYMS—urinary bladder cancer	9.47e-06	6.92e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	9.45e-06	6.89e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	9.45e-06	6.89e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	9.42e-06	6.88e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—NCOR1—urinary bladder cancer	9.36e-06	6.84e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTM1—urinary bladder cancer	9.36e-06	6.84e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CREBBP—urinary bladder cancer	9.16e-06	6.69e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CREBBP—urinary bladder cancer	9.14e-06	6.68e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—MTHFR—urinary bladder cancer	9.08e-06	6.63e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	9.05e-06	6.6e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—urinary bladder cancer	9.03e-06	6.6e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—urinary bladder cancer	9.02e-06	6.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CREBBP—urinary bladder cancer	9.01e-06	6.57e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PPARG—urinary bladder cancer	8.99e-06	6.57e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GPX1—urinary bladder cancer	8.97e-06	6.55e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IGF1—urinary bladder cancer	8.89e-06	6.49e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	8.88e-06	6.48e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	8.86e-06	6.47e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—EGFR—urinary bladder cancer	8.85e-06	6.46e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	8.83e-06	6.45e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ERCC2—urinary bladder cancer	8.8e-06	6.43e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—urinary bladder cancer	8.71e-06	6.36e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—CREBBP—urinary bladder cancer	8.64e-06	6.31e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—EP300—urinary bladder cancer	8.62e-06	6.29e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—EP300—urinary bladder cancer	8.6e-06	6.28e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	8.42e-06	6.15e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—urinary bladder cancer	8.41e-06	6.14e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—urinary bladder cancer	8.36e-06	6.1e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	8.35e-06	6.09e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—MTHFR—urinary bladder cancer	8.28e-06	6.04e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PPARG—urinary bladder cancer	8.25e-06	6.02e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RHOA—urinary bladder cancer	8.15e-06	5.95e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—TYMS—urinary bladder cancer	8.1e-06	5.91e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	8.06e-06	5.88e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—EP300—urinary bladder cancer	8.02e-06	5.85e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—NCOR1—urinary bladder cancer	8e-06	5.84e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTM1—urinary bladder cancer	8e-06	5.84e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CREBBP—urinary bladder cancer	7.92e-06	5.78e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GPX1—urinary bladder cancer	7.66e-06	5.59e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB2—urinary bladder cancer	7.54e-06	5.51e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ERCC2—urinary bladder cancer	7.52e-06	5.49e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTGS2—urinary bladder cancer	7.5e-06	5.48e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTGS2—urinary bladder cancer	7.49e-06	5.47e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PPARG—urinary bladder cancer	7.36e-06	5.37e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PPARG—urinary bladder cancer	7.18e-06	5.24e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CXCL8—urinary bladder cancer	7.15e-06	5.22e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—HRAS—urinary bladder cancer	7.11e-06	5.19e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTGS2—urinary bladder cancer	7.07e-06	5.16e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—MTHFR—urinary bladder cancer	7.07e-06	5.16e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CREBBP—urinary bladder cancer	7.07e-06	5.16e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	6.9e-06	5.04e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—urinary bladder cancer	6.84e-06	4.99e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	6.77e-06	4.94e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	6.72e-06	4.91e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PPARG—urinary bladder cancer	6.71e-06	4.9e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—urinary bladder cancer	6.66e-06	4.86e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—urinary bladder cancer	6.54e-06	4.78e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—urinary bladder cancer	6.53e-06	4.77e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	6.5e-06	4.75e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTGS2—urinary bladder cancer	6.49e-06	4.73e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MMP9—urinary bladder cancer	6.47e-06	4.72e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CREBBP—urinary bladder cancer	6.45e-06	4.71e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1A—urinary bladder cancer	6.45e-06	4.71e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—urinary bladder cancer	6.43e-06	4.69e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	6.25e-06	4.56e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—EP300—urinary bladder cancer	6.24e-06	4.56e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—EP300—urinary bladder cancer	6.23e-06	4.55e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	6.18e-06	4.51e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	6.18e-06	4.51e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—urinary bladder cancer	6.17e-06	4.5e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EP300—urinary bladder cancer	6.13e-06	4.48e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—SRC—urinary bladder cancer	5.96e-06	4.35e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	5.91e-06	4.32e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—EP300—urinary bladder cancer	5.88e-06	4.3e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	5.81e-06	4.24e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTGS2—urinary bladder cancer	5.79e-06	4.23e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PPARG—urinary bladder cancer	5.73e-06	4.19e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—urinary bladder cancer	5.66e-06	4.13e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	5.65e-06	4.12e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CREBBP—urinary bladder cancer	5.51e-06	4.02e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	5.46e-06	3.98e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—EP300—urinary bladder cancer	5.39e-06	3.94e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—urinary bladder cancer	5.34e-06	3.9e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	5.32e-06	3.89e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS2—urinary bladder cancer	5.28e-06	3.85e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—EGFR—urinary bladder cancer	5.23e-06	3.82e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—urinary bladder cancer	5.05e-06	3.69e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—urinary bladder cancer	4.94e-06	3.6e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—urinary bladder cancer	4.93e-06	3.6e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—EP300—urinary bladder cancer	4.82e-06	3.51e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—EP300—urinary bladder cancer	4.7e-06	3.43e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	4.64e-06	3.39e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—urinary bladder cancer	4.6e-06	3.36e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS2—urinary bladder cancer	4.51e-06	3.29e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—EP300—urinary bladder cancer	4.43e-06	3.23e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	4.43e-06	3.23e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—EP300—urinary bladder cancer	4.39e-06	3.2e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—urinary bladder cancer	4.39e-06	3.2e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	4.25e-06	3.1e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HRAS—urinary bladder cancer	4.2e-06	3.06e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—urinary bladder cancer	3.93e-06	2.87e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—EP300—urinary bladder cancer	3.75e-06	2.74e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	3.48e-06	2.54e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	3.04e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—EP300—urinary bladder cancer	2.9e-06	2.11e-05	CbGpPWpGaD
